Yang ZJ, Zhang YR, Chen B, Zhang SL, Jia EZ, Wang LS, et al. (July 2009). "Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease". Molecular Biology Reports. 36 (6): 1323–1329. doi:10.1007/s11033-008-9315-3. PMID18649012. S2CID23419866.
Hahn W, Pyun WB, Kim DS, Yoo WS, Lee SD, Won JH, et al. (October 2011). "Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model". The Journal of Gene Medicine. 13 (10): 549–555. doi:10.1002/jgm.1603. PMID21898720. S2CID26812780.
Niranjan B, Buluwela L, Yant J, Perusinghe N, Atherton A, Phippard D, et al. (September 1995). "HGF/SF: a potent cytokine for mammary growth, morphogenesis and development". Development. 121 (9): 2897–2908. doi:10.1242/dev.121.9.2897. PMID7555716.
Kamalati T, Niranjan B, Yant J, Buluwela L (January 1999). "HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models". Journal of Mammary Gland Biology and Neoplasia. 4 (1): 69–77. doi:10.1023/A:1018756620265. PMID10219907. S2CID9310133.
Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, et al. (September 2013). "A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure". International Journal of Cardiology. 168 (2): 1251–1257. doi:10.1016/j.ijcard.2012.11.052. PMID23218577.
Rychli K, Richter B, Hohensinner PJ, Kariem Mahdy A, Neuhold S, Zorn G, et al. (July 2011). "Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure". Heart. 97 (14): 1158–1163. doi:10.1136/hrt.2010.220228. PMID21572126. S2CID22426278.
Nakamura S, Morishita R, Moriguchi A, Yo Y, Nakamura Y, Hayashi S, et al. (December 1998). "Hepatocyte growth factor as a potential index of complication in diabetes mellitus". Journal of Hypertension. 16 (12 Pt 2): 2019–2026. doi:10.1097/00004872-199816121-00025. PMID9886892. S2CID6615179.
Wright JW, Harding JW (January 2015). "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease". Journal of Alzheimer's Disease. 45 (4): 985–1000. doi:10.3233/JAD-142814. PMID25649658.
Hu B, Yin N, Yang R, Liang S, Liang S, Faiola F (July 2020). "Silver nanoparticles (AgNPs) and AgNO3 perturb the specification of human hepatocyte-like cells and cardiomyocytes". The Science of the Total Environment. 725 138433. Bibcode:2020ScTEn.72538433H. doi:10.1016/j.scitotenv.2020.138433. PMID32302844.
Wright JW, Harding JW (2015). "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease". Journal of Alzheimer's Disease. 45 (4): 985–1000. doi:10.3233/JAD-142814. PMID25649658.
Wright JW, Kawas LH, Harding JW (February 2015). "The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases". Progress in Neurobiology. 125: 26–46. doi:10.1016/j.pneurobio.2014.11.004. PMID25455861. S2CID41360989.
Johnson M, Koukoulis G, Kochhar K, Kubo C, Nakamura T, Iyer A (September 1995). "Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection". Cancer Letters. 96 (1): 37–48. doi:10.1016/0304-3835(95)03915-j. PMID7553606.
Kochhar KS, Johnson ME, Volpert O, Iyer AP (1995). "Evidence for autocrine basis of transformation in NIH-3T3 cells transfected with met/HGF receptor gene". Growth Factors. 12 (4): 303–313. doi:10.3109/08977199509028968. PMID8930021.
Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, et al. (February 1991). "Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product". Science. 251 (4995): 802–804. Bibcode:1991Sci...251..802B. doi:10.1126/science.1846706. PMID1846706.
Hu B, Yin N, Yang R, Liang S, Liang S, Faiola F (July 2020). "Silver nanoparticles (AgNPs) and AgNO3 perturb the specification of human hepatocyte-like cells and cardiomyocytes". The Science of the Total Environment. 725 138433. Bibcode:2020ScTEn.72538433H. doi:10.1016/j.scitotenv.2020.138433. PMID32302844.
Yang ZJ, Zhang YR, Chen B, Zhang SL, Jia EZ, Wang LS, et al. (July 2009). "Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease". Molecular Biology Reports. 36 (6): 1323–1329. doi:10.1007/s11033-008-9315-3. PMID18649012. S2CID23419866.
Hahn W, Pyun WB, Kim DS, Yoo WS, Lee SD, Won JH, et al. (October 2011). "Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model". The Journal of Gene Medicine. 13 (10): 549–555. doi:10.1002/jgm.1603. PMID21898720. S2CID26812780.
Niranjan B, Buluwela L, Yant J, Perusinghe N, Atherton A, Phippard D, et al. (September 1995). "HGF/SF: a potent cytokine for mammary growth, morphogenesis and development". Development. 121 (9): 2897–2908. doi:10.1242/dev.121.9.2897. PMID7555716.
Kamalati T, Niranjan B, Yant J, Buluwela L (January 1999). "HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models". Journal of Mammary Gland Biology and Neoplasia. 4 (1): 69–77. doi:10.1023/A:1018756620265. PMID10219907. S2CID9310133.
Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, et al. (September 2013). "A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure". International Journal of Cardiology. 168 (2): 1251–1257. doi:10.1016/j.ijcard.2012.11.052. PMID23218577.
Rychli K, Richter B, Hohensinner PJ, Kariem Mahdy A, Neuhold S, Zorn G, et al. (July 2011). "Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure". Heart. 97 (14): 1158–1163. doi:10.1136/hrt.2010.220228. PMID21572126. S2CID22426278.
Nakamura S, Morishita R, Moriguchi A, Yo Y, Nakamura Y, Hayashi S, et al. (December 1998). "Hepatocyte growth factor as a potential index of complication in diabetes mellitus". Journal of Hypertension. 16 (12 Pt 2): 2019–2026. doi:10.1097/00004872-199816121-00025. PMID9886892. S2CID6615179.
Appasamy R, Tanabe M, Murase N, Zarnegar R, Venkataramanan R, Van Thiel DH, et al. (March 1993). "Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats". Laboratory Investigation; A Journal of Technical Methods and Pathology. 68 (3): 270–276. PMID8450646.
Kato Y, Liu KX, Nakamura T, Sugiyama Y (August 1994). "Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity". Hepatology. 20 (2): 417–424. doi:10.1002/hep.1840200223. PMID8045504. S2CID20021569.
Wright JW, Harding JW (January 2015). "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease". Journal of Alzheimer's Disease. 45 (4): 985–1000. doi:10.3233/JAD-142814. PMID25649658.
Hu B, Yin N, Yang R, Liang S, Liang S, Faiola F (July 2020). "Silver nanoparticles (AgNPs) and AgNO3 perturb the specification of human hepatocyte-like cells and cardiomyocytes". The Science of the Total Environment. 725 138433. Bibcode:2020ScTEn.72538433H. doi:10.1016/j.scitotenv.2020.138433. PMID32302844.
Wright JW, Harding JW (2015). "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease". Journal of Alzheimer's Disease. 45 (4): 985–1000. doi:10.3233/JAD-142814. PMID25649658.
Wright JW, Kawas LH, Harding JW (February 2015). "The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases". Progress in Neurobiology. 125: 26–46. doi:10.1016/j.pneurobio.2014.11.004. PMID25455861. S2CID41360989.
Comoglio PM (1993). "Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells". Exs. 65: 131–165. PMID8380735.
Johnson M, Koukoulis G, Kochhar K, Kubo C, Nakamura T, Iyer A (September 1995). "Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection". Cancer Letters. 96 (1): 37–48. doi:10.1016/0304-3835(95)03915-j. PMID7553606.
Kochhar KS, Johnson ME, Volpert O, Iyer AP (1995). "Evidence for autocrine basis of transformation in NIH-3T3 cells transfected with met/HGF receptor gene". Growth Factors. 12 (4): 303–313. doi:10.3109/08977199509028968. PMID8930021.
Yang ZJ, Zhang YR, Chen B, Zhang SL, Jia EZ, Wang LS, et al. (July 2009). "Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease". Molecular Biology Reports. 36 (6): 1323–1329. doi:10.1007/s11033-008-9315-3. PMID18649012. S2CID23419866.
Hahn W, Pyun WB, Kim DS, Yoo WS, Lee SD, Won JH, et al. (October 2011). "Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model". The Journal of Gene Medicine. 13 (10): 549–555. doi:10.1002/jgm.1603. PMID21898720. S2CID26812780.
Kamalati T, Niranjan B, Yant J, Buluwela L (January 1999). "HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models". Journal of Mammary Gland Biology and Neoplasia. 4 (1): 69–77. doi:10.1023/A:1018756620265. PMID10219907. S2CID9310133.
Rychli K, Richter B, Hohensinner PJ, Kariem Mahdy A, Neuhold S, Zorn G, et al. (July 2011). "Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure". Heart. 97 (14): 1158–1163. doi:10.1136/hrt.2010.220228. PMID21572126. S2CID22426278.
Nakamura S, Morishita R, Moriguchi A, Yo Y, Nakamura Y, Hayashi S, et al. (December 1998). "Hepatocyte growth factor as a potential index of complication in diabetes mellitus". Journal of Hypertension. 16 (12 Pt 2): 2019–2026. doi:10.1097/00004872-199816121-00025. PMID9886892. S2CID6615179.
Kato Y, Liu KX, Nakamura T, Sugiyama Y (August 1994). "Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity". Hepatology. 20 (2): 417–424. doi:10.1002/hep.1840200223. PMID8045504. S2CID20021569.
Wright JW, Kawas LH, Harding JW (February 2015). "The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases". Progress in Neurobiology. 125: 26–46. doi:10.1016/j.pneurobio.2014.11.004. PMID25455861. S2CID41360989.